The USA-headquartered Alliance for the Prudent Use of Antibiotics has announced plans to explore ways of preventing millions of avoidable deaths in Africa, with the help of a grant by the Bill & Melinda Gates Foundation. Stuart Levy, the APUA's president and professor of medicine and microbiology at Tuft's University School of Medicine in Boston, Massachusetts, said: "because of rapidly increasing antibiotic resistance, no currently available antibiotic can be assumed to be active against a particular pathogen. Continual monitoring is needed to determine the right drug choice."
The Gates Foundation donation will be used for several activities, including: organizing fast-track delivery systems for medicines in Uganda and Zambia, improving the proper dispensing of pharmaceutical products via legitimate channels; and monitoring illegitimate distribution which, in Africa, often involves street peddlars of unreliably-sourced drugs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze